| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HELIYON.2018.E00562 |
| P8608 | Fatcat ID | release_2hy4zeewqnb7zgvohxfnnbbcp4 |
| P932 | PMC publication ID | 5857811 |
| P698 | PubMed publication ID | 29560472 |
| P2093 | author name string | Philip Murphy | |
| Priya Kapoor | |||
| P2860 | cites work | Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia | Q24672751 |
| Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients | Q24673399 | ||
| Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia | Q29615286 | ||
| Rapid identification and antibiotic susceptibility testing of Salmonella enterica serovar Typhi isolated from blood: implications for therapy | Q33973639 | ||
| Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype | Q34001834 | ||
| Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm | Q34088017 | ||
| Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa | Q34143161 | ||
| Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes | Q34757004 | ||
| Theoretical aspects of antibiotic diffusion into microbial biofilms | Q35128954 | ||
| Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia | Q35685688 | ||
| Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection | Q36061216 | ||
| The application of biofilm science to the study and control of chronic bacterial infections | Q36991151 | ||
| Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates. | Q38741337 | ||
| Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. | Q39695206 | ||
| Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis | Q40834016 | ||
| Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation | Q42674600 | ||
| Epidemiologic Study of Pseudomonas aeruginosa in critical patients and reservoirs | Q43631926 | ||
| Gene expression in Pseudomonas aeruginosa biofilms | Q43777487 | ||
| Involvement of motility and flagella in Bacillus cereus biofilm formation | Q43792605 | ||
| Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections | Q46159791 | ||
| Biofilm formation by Scottish clinical isolates of Staphylococcus aureus | Q46482891 | ||
| Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia | Q73675033 | ||
| Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method | Q73729017 | ||
| Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12) | Q88056202 | ||
| P433 | issue | 3 | |
| P921 | main subject | antibiotic | Q12187 |
| cystic fibrosis | Q178194 | ||
| Pseudomonas aeruginosa | Q31856 | ||
| P304 | page(s) | e00562 | |
| P577 | publication date | 2018-03-08 | |
| P1433 | published in | Heliyon | Q27727019 |
| P1476 | title | Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics. | |
| P478 | volume | 4 |
Search more.